Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stomach Neoplasms | 15 | 2020 | 1332 | 1.710 |
Why?
|
Pancreatic Neoplasms | 8 | 2022 | 5263 | 1.510 |
Why?
|
Pancreatectomy | 5 | 2022 | 804 | 1.350 |
Why?
|
Adenocarcinoma | 13 | 2022 | 6364 | 1.100 |
Why?
|
Veterans Health | 3 | 2022 | 216 | 1.080 |
Why?
|
Carcinoid Tumor | 3 | 2012 | 235 | 1.080 |
Why?
|
Pancreaticoduodenectomy | 5 | 2020 | 503 | 1.010 |
Why?
|
Gastrointestinal Stromal Tumors | 5 | 2009 | 643 | 0.830 |
Why?
|
Biliary Tract | 1 | 2019 | 134 | 0.630 |
Why?
|
Bile | 1 | 2019 | 299 | 0.620 |
Why?
|
Nomograms | 2 | 2009 | 228 | 0.570 |
Why?
|
Appendicitis | 1 | 2023 | 645 | 0.570 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 140 | 0.500 |
Why?
|
Neoplasm Staging | 10 | 2016 | 11031 | 0.500 |
Why?
|
Hepatectomy | 3 | 2019 | 550 | 0.490 |
Why?
|
Colonic Neoplasms | 3 | 2014 | 2542 | 0.490 |
Why?
|
Chemokine CCL20 | 1 | 2014 | 65 | 0.480 |
Why?
|
Piperazines | 4 | 2009 | 2488 | 0.470 |
Why?
|
Receptors, CCR6 | 1 | 2014 | 81 | 0.470 |
Why?
|
Genes, APC | 1 | 2014 | 159 | 0.460 |
Why?
|
Interleukin-17 | 2 | 2015 | 901 | 0.430 |
Why?
|
Pyrimidines | 4 | 2009 | 2943 | 0.430 |
Why?
|
Lymphatic Metastasis | 8 | 2018 | 2924 | 0.420 |
Why?
|
Healthcare Disparities | 3 | 2022 | 3154 | 0.420 |
Why?
|
Colectomy | 2 | 2020 | 680 | 0.410 |
Why?
|
Colorectal Neoplasms | 7 | 2021 | 6773 | 0.410 |
Why?
|
Intestinal Neoplasms | 1 | 2014 | 319 | 0.400 |
Why?
|
Pancreas | 4 | 2022 | 1687 | 0.400 |
Why?
|
Lymph Node Excision | 4 | 2016 | 1262 | 0.400 |
Why?
|
Survival Rate | 11 | 2021 | 12788 | 0.390 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 604 | 0.390 |
Why?
|
Lymph Nodes | 3 | 2011 | 3476 | 0.390 |
Why?
|
Postoperative Complications | 8 | 2020 | 15297 | 0.380 |
Why?
|
Early Diagnosis | 1 | 2016 | 1184 | 0.380 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2006 | 990 | 0.360 |
Why?
|
Health Status Disparities | 1 | 2021 | 1796 | 0.350 |
Why?
|
Vaccines, DNA | 4 | 2006 | 305 | 0.350 |
Why?
|
Patient Discharge | 5 | 2020 | 3318 | 0.350 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1636 | 0.330 |
Why?
|
Veterans | 1 | 2022 | 2519 | 0.320 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2016 | 868 | 0.320 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2943 | 0.300 |
Why?
|
Antineoplastic Agents | 7 | 2015 | 13693 | 0.300 |
Why?
|
Duodenal Neoplasms | 1 | 2007 | 106 | 0.290 |
Why?
|
Incidental Findings | 1 | 2012 | 689 | 0.290 |
Why?
|
Bile Ducts | 2 | 2019 | 284 | 0.290 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7785 | 0.280 |
Why?
|
Melanoma | 7 | 2023 | 5511 | 0.280 |
Why?
|
Gastrectomy | 6 | 2018 | 663 | 0.280 |
Why?
|
Antigens, Heterophile | 2 | 2003 | 69 | 0.270 |
Why?
|
Mediastinal Diseases | 1 | 2006 | 89 | 0.270 |
Why?
|
Digestive System Surgical Procedures | 2 | 2016 | 576 | 0.260 |
Why?
|
Skilled Nursing Facilities | 2 | 2019 | 372 | 0.260 |
Why?
|
Sternum | 1 | 2006 | 177 | 0.260 |
Why?
|
Cholestasis | 2 | 2019 | 378 | 0.250 |
Why?
|
Streptococcus bovis | 1 | 2004 | 4 | 0.250 |
Why?
|
Hyperparathyroidism | 1 | 2006 | 339 | 0.250 |
Why?
|
Prognosis | 14 | 2021 | 29060 | 0.250 |
Why?
|
SEER Program | 3 | 2015 | 1507 | 0.230 |
Why?
|
Insurance, Health | 1 | 2016 | 2494 | 0.230 |
Why?
|
Protein Kinase Inhibitors | 3 | 2009 | 5534 | 0.220 |
Why?
|
Aged | 35 | 2021 | 163288 | 0.220 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2007 | 710 | 0.210 |
Why?
|
Middle Aged | 38 | 2021 | 213390 | 0.210 |
Why?
|
Humans | 65 | 2023 | 744366 | 0.210 |
Why?
|
Melanoma, Experimental | 2 | 2003 | 561 | 0.210 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 713 | 0.210 |
Why?
|
Cardia | 2 | 2020 | 57 | 0.210 |
Why?
|
Patient Transfer | 2 | 2019 | 762 | 0.200 |
Why?
|
Benzamides | 4 | 2009 | 1379 | 0.200 |
Why?
|
Esophageal Neoplasms | 3 | 2020 | 1585 | 0.200 |
Why?
|
Neoadjuvant Therapy | 4 | 2019 | 2727 | 0.200 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5692 | 0.190 |
Why?
|
Male | 42 | 2021 | 350115 | 0.190 |
Why?
|
Fibroma | 1 | 2002 | 212 | 0.180 |
Why?
|
Appendectomy | 1 | 2023 | 401 | 0.180 |
Why?
|
Aged, 80 and over | 18 | 2018 | 57776 | 0.180 |
Why?
|
Streptococcal Infections | 1 | 2004 | 638 | 0.180 |
Why?
|
Reoperation | 3 | 2019 | 4201 | 0.170 |
Why?
|
Female | 42 | 2021 | 380193 | 0.170 |
Why?
|
Cell Proliferation | 5 | 2018 | 10483 | 0.170 |
Why?
|
Cancer Vaccines | 3 | 2003 | 1023 | 0.170 |
Why?
|
Neoplasm Invasiveness | 6 | 2018 | 3616 | 0.170 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2003 | 880 | 0.170 |
Why?
|
Retrospective Studies | 17 | 2021 | 77460 | 0.160 |
Why?
|
Esophagogastric Junction | 3 | 2020 | 313 | 0.160 |
Why?
|
Thymosin | 1 | 1997 | 47 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 498 | 0.150 |
Why?
|
Neoplasm Proteins | 3 | 2011 | 3707 | 0.150 |
Why?
|
Rehabilitation Centers | 1 | 2019 | 254 | 0.150 |
Why?
|
Bacteremia | 1 | 2004 | 963 | 0.150 |
Why?
|
Patient Selection | 1 | 2009 | 4216 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 2020 | 374 | 0.150 |
Why?
|
Length of Stay | 5 | 2020 | 6311 | 0.140 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6313 | 0.140 |
Why?
|
Hospices | 1 | 2019 | 265 | 0.140 |
Why?
|
Proportional Hazards Models | 7 | 2015 | 12356 | 0.130 |
Why?
|
Transcription Factors | 1 | 2015 | 12207 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 5 | 2015 | 6539 | 0.130 |
Why?
|
Membrane Glycoproteins | 3 | 2003 | 3771 | 0.130 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1107 | 0.130 |
Why?
|
Cell Movement | 2 | 2018 | 5218 | 0.130 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39052 | 0.130 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 1799 | 0.130 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 345 | 0.130 |
Why?
|
Morbidity | 1 | 2020 | 1768 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2019 | 3480 | 0.120 |
Why?
|
Digestive System Diseases | 1 | 2016 | 147 | 0.120 |
Why?
|
Choristoma | 1 | 2016 | 214 | 0.120 |
Why?
|
Sex Factors | 4 | 2021 | 10400 | 0.120 |
Why?
|
Carcinoma | 2 | 2015 | 2375 | 0.110 |
Why?
|
Risk Factors | 13 | 2020 | 72296 | 0.110 |
Why?
|
Carcinoma, Lobular | 1 | 1997 | 484 | 0.110 |
Why?
|
Adult | 22 | 2018 | 214052 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1376 | 0.110 |
Why?
|
Acute Disease | 1 | 2023 | 7147 | 0.110 |
Why?
|
Specialties, Surgical | 1 | 2017 | 391 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1602 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2002 | 1363 | 0.100 |
Why?
|
China | 5 | 2016 | 2245 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2008 | 4253 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2023 | 63107 | 0.100 |
Why?
|
Carcinoma in Situ | 1 | 1997 | 806 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2008 | 9240 | 0.100 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1970 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2017 | 722 | 0.100 |
Why?
|
Peritoneum | 1 | 2012 | 228 | 0.100 |
Why?
|
Time Factors | 8 | 2020 | 40075 | 0.100 |
Why?
|
Stromal Cells | 1 | 2016 | 1355 | 0.100 |
Why?
|
Stomach | 1 | 2015 | 697 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2016 | 15078 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1997 | 1100 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2505 | 0.090 |
Why?
|
Perioperative Care | 1 | 2017 | 1002 | 0.090 |
Why?
|
Phosphoproteins | 1 | 1998 | 2441 | 0.090 |
Why?
|
Mitotic Index | 1 | 2009 | 172 | 0.090 |
Why?
|
Survival Analysis | 6 | 2008 | 10252 | 0.090 |
Why?
|
Risk Assessment | 7 | 2019 | 23336 | 0.090 |
Why?
|
World Health Organization | 1 | 2015 | 1318 | 0.090 |
Why?
|
Stents | 2 | 2020 | 3282 | 0.080 |
Why?
|
Neoplasm Metastasis | 4 | 2007 | 4851 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3519 | 0.080 |
Why?
|
Spain | 1 | 2009 | 465 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5172 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2011 | 640 | 0.070 |
Why?
|
Telomere | 1 | 2013 | 910 | 0.070 |
Why?
|
Mice | 11 | 2018 | 81201 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1915 | 0.070 |
Why?
|
Adolescent | 9 | 2016 | 85779 | 0.070 |
Why?
|
Dacarbazine | 1 | 2010 | 566 | 0.070 |
Why?
|
Immunotherapy, Active | 1 | 2006 | 60 | 0.070 |
Why?
|
Mice, Inbred C57BL | 7 | 2014 | 21833 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4751 | 0.070 |
Why?
|
Fluorouracil | 1 | 2011 | 1619 | 0.070 |
Why?
|
Blotting, Western | 1 | 2014 | 5181 | 0.070 |
Why?
|
gp100 Melanoma Antigen | 2 | 2003 | 39 | 0.070 |
Why?
|
Young Adult | 5 | 2016 | 56429 | 0.070 |
Why?
|
Metaplasia | 2 | 2020 | 313 | 0.070 |
Why?
|
Disease-Free Survival | 3 | 2009 | 6896 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2008 | 776 | 0.070 |
Why?
|
Esophagus | 1 | 2011 | 1019 | 0.070 |
Why?
|
Endoscopy | 2 | 2015 | 1787 | 0.060 |
Why?
|
Databases as Topic | 1 | 2007 | 475 | 0.060 |
Why?
|
United States | 6 | 2019 | 69872 | 0.060 |
Why?
|
Autoantigens | 2 | 2006 | 892 | 0.060 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8642 | 0.060 |
Why?
|
Incidence | 3 | 2018 | 20952 | 0.060 |
Why?
|
Age Factors | 3 | 2020 | 18373 | 0.060 |
Why?
|
Animals | 13 | 2021 | 168768 | 0.060 |
Why?
|
Asparagine | 1 | 2003 | 122 | 0.060 |
Why?
|
Massachusetts | 1 | 2016 | 8662 | 0.060 |
Why?
|
Databases, Factual | 4 | 2020 | 7730 | 0.060 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2003 | 370 | 0.050 |
Why?
|
H-2 Antigens | 1 | 2003 | 366 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2003 | 425 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2006 | 4386 | 0.050 |
Why?
|
Tibial Nerve | 1 | 2002 | 50 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8432 | 0.050 |
Why?
|
Comorbidity | 3 | 2020 | 10388 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2003 | 1369 | 0.050 |
Why?
|
Apoptosis | 2 | 2018 | 9724 | 0.050 |
Why?
|
Peroneal Nerve | 1 | 2002 | 74 | 0.050 |
Why?
|
Prospective Studies | 5 | 2018 | 53290 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3508 | 0.050 |
Why?
|
Genes, Neoplasm | 1 | 2003 | 376 | 0.050 |
Why?
|
Adjuvants, Immunologic | 1 | 2006 | 1000 | 0.050 |
Why?
|
Neoplasms | 3 | 2006 | 21696 | 0.050 |
Why?
|
Tryptophan | 1 | 2003 | 478 | 0.050 |
Why?
|
Patient Readmission | 3 | 2020 | 3116 | 0.050 |
Why?
|
Denervation | 1 | 2002 | 278 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 3554 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1879 | 0.050 |
Why?
|
Neoplasms, Experimental | 1 | 2006 | 1276 | 0.050 |
Why?
|
Ostomy | 1 | 2020 | 27 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20130 | 0.040 |
Why?
|
Child | 4 | 2011 | 77709 | 0.040 |
Why?
|
Quality Improvement | 3 | 2020 | 3749 | 0.040 |
Why?
|
Limb Salvage | 1 | 2002 | 433 | 0.040 |
Why?
|
Age Distribution | 2 | 2016 | 2902 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16690 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2014 | 14561 | 0.040 |
Why?
|
Catenins | 1 | 1998 | 41 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 13035 | 0.040 |
Why?
|
Oximes | 1 | 2020 | 311 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2003 | 1793 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.040 |
Why?
|
Sciatic Nerve | 1 | 2002 | 607 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11486 | 0.040 |
Why?
|
Autoimmunity | 1 | 2006 | 1350 | 0.040 |
Why?
|
Rhabdomyosarcoma | 1 | 2001 | 382 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2020 | 370 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11366 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2015 | 5181 | 0.040 |
Why?
|
Uveal Neoplasms | 1 | 2020 | 310 | 0.040 |
Why?
|
Helicobacter pylori | 1 | 2020 | 383 | 0.040 |
Why?
|
Ureter | 1 | 2020 | 375 | 0.040 |
Why?
|
Helicobacter Infections | 1 | 2020 | 387 | 0.040 |
Why?
|
Fluorescein | 1 | 2017 | 171 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2002 | 973 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2006 | 2455 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2006 | 13814 | 0.040 |
Why?
|
Colonoscopy | 1 | 2004 | 1367 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 7023 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2006 | 4479 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2003 | 2216 | 0.030 |
Why?
|
Pyridones | 1 | 2020 | 711 | 0.030 |
Why?
|
Bilirubin | 1 | 2017 | 425 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 537 | 0.030 |
Why?
|
Health Status | 2 | 2019 | 4034 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1342 | 0.030 |
Why?
|
Gastroscopy | 1 | 2016 | 207 | 0.030 |
Why?
|
Syndecan-1 | 1 | 2015 | 165 | 0.030 |
Why?
|
Antigens, Neoplasm | 4 | 2006 | 1988 | 0.030 |
Why?
|
Breast Diseases | 1 | 1997 | 443 | 0.030 |
Why?
|
North America | 1 | 2018 | 1249 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12244 | 0.030 |
Why?
|
Biopsy | 2 | 2016 | 6755 | 0.030 |
Why?
|
Intramolecular Oxidoreductases | 2 | 2006 | 109 | 0.030 |
Why?
|
Serum Albumin | 1 | 2017 | 675 | 0.030 |
Why?
|
Registries | 1 | 2009 | 8091 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 18111 | 0.030 |
Why?
|
Imidazoles | 1 | 2020 | 1206 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2000 | 1821 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2259 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1341 | 0.030 |
Why?
|
Models, Statistical | 1 | 2007 | 5101 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13409 | 0.030 |
Why?
|
Cytokines | 1 | 2006 | 7323 | 0.020 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2011 | 88 | 0.020 |
Why?
|
Osteoclasts | 1 | 2015 | 729 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1461 | 0.020 |
Why?
|
Recovery of Function | 2 | 2017 | 2926 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 19905 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11525 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2297 | 0.020 |
Why?
|
Protein Binding | 1 | 2003 | 9384 | 0.020 |
Why?
|
Thromboembolism | 1 | 2017 | 987 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2003 | 5096 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1655 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2182 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1301 | 0.020 |
Why?
|
Sarcoma | 1 | 2002 | 1897 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 1997 | 20824 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 1917 | 0.020 |
Why?
|
Forecasting | 1 | 2018 | 2951 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2725 | 0.020 |
Why?
|
Genomic Instability | 1 | 2013 | 695 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2010 | 206 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1257 | 0.020 |
Why?
|
Postoperative Care | 1 | 2015 | 1487 | 0.020 |
Why?
|
Breast | 1 | 1997 | 1970 | 0.020 |
Why?
|
Telomerase | 1 | 2013 | 730 | 0.020 |
Why?
|
Up-Regulation | 1 | 1997 | 4222 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2010 | 349 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2002 | 903 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2006 | 91 | 0.020 |
Why?
|
Hypopigmentation | 1 | 2006 | 41 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 378 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2716 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3203 | 0.020 |
Why?
|
Self Tolerance | 1 | 2006 | 125 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4446 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5717 | 0.020 |
Why?
|
Mutation | 2 | 2008 | 29786 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18034 | 0.020 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2006 | 279 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2004 | 25628 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2006 | 580 | 0.010 |
Why?
|
Cross Reactions | 1 | 2006 | 841 | 0.010 |
Why?
|
COS Cells | 1 | 2006 | 1161 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2006 | 6621 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9955 | 0.010 |
Why?
|
Gene Library | 1 | 2006 | 1074 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2006 | 2050 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3086 | 0.010 |
Why?
|
Infant | 1 | 2004 | 35134 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14723 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3505 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2003 | 964 | 0.010 |
Why?
|
Child, Preschool | 1 | 2004 | 41005 | 0.010 |
Why?
|
Plasmids | 1 | 2006 | 2308 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12961 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2015 | 4232 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21748 | 0.010 |
Why?
|
Vaccination | 2 | 2003 | 3279 | 0.010 |
Why?
|
Self-Assessment | 1 | 2002 | 390 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2003 | 565 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2003 | 593 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2850 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 2002 | 13104 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5867 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2001 | 927 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2002 | 2086 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5895 | 0.010 |
Why?
|
Immunization | 1 | 2002 | 1256 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2000 | 936 | 0.010 |
Why?
|
Diet | 1 | 2015 | 7937 | 0.010 |
Why?
|
Leg | 1 | 2002 | 1116 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2002 | 1758 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 2256 | 0.010 |
Why?
|
DNA Methylation | 1 | 2010 | 4285 | 0.010 |
Why?
|
Antibody Formation | 1 | 2000 | 1402 | 0.010 |
Why?
|
Testicular Neoplasms | 1 | 2001 | 806 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12797 | 0.010 |
Why?
|
Spleen | 1 | 2000 | 2362 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6386 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 2865 | 0.010 |
Why?
|
Graft Rejection | 1 | 2006 | 4397 | 0.010 |
Why?
|
Cell Division | 1 | 2000 | 4569 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2003 | 2725 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2000 | 3424 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2006 | 10183 | 0.010 |
Why?
|
Quality of Life | 1 | 2002 | 12802 | 0.000 |
Why?
|